TSUMURA & CO.
Announcement of Second Quarter Financial Results・The Medium-Term Management Plan
November 9, 2012
Font Size
sm
md
lg
TSUMURA & CO.
Announcement of Second Quarter Financial Results・The Medium-Term Management Plan
Terukazu Kato
President,
Representative Director
from the beginning
Second Quarter Business Results for Fiscal 2012
presenter :
Terukazu Kato
President, Representative Director
2Q Consolidated Performance for Fiscal 2012, ending March 31, 2013
Key Points in 2Q Performance
Top 10 Kampo Products by Sales Amount
MR Activities (1): Sales Calls on Physicians
MR Activities (2): Medical Institution Information Meetings
MR Activities (3): Kampo Medicine Seminars
Growth in Physicians Prescribing Kampo Medicine
Analysis of 2Q Cost of Sales Ratio Compared with Last Fiscal Year
Analysis of Inventories Increase
Revision of FY2012 Full-Year Performance Forecasts
Medium-Term Management Plan(FY2012-2015)
Basic Policies
Philosophy-Based Management
Basic Philosophy
Long-Term Business Vision “2021 Vision”
FY2012-2015 Medium-Term Management Plan
Operating Environment: The Future of Medical Treatment in Japan
Strengthening the Growth Base to Achieve Greater Value Creation
Positioning of the New Medium-Term Management Plan
Strategic Issues
Reaching Cruising Speed for Boosting Growth and Corporate Value
FY2015 (ending March 31, 2016) Performance Targets
Strategic Issue 1:Expanding the Kampo Medicine Market
Expansion Strategy for Kampo Medicine Market
Strategic Expansion in Use of Different Kampo Formulations
Kampo Medicine Education System
Double Blind Trials (DBT) of“ Drug Fostering Program” Formulations
Sales Forecast: Past Trends and Cumulative Growth in Formulations
Strategic Issue 1:Expanding the Kampo Medicine Market
Strategic Issue 2:Enhancing Earning Power
Improvement in Profitability Scenario from a Medium-Term Perspective
Reform of Cost Structure
Measures to Reduce Manufacturing Cost
Raising Productivity Through the Introduction of New Production Technology and Other Measures
Stability of Crude Drug Prices
Impact on Cost of Sales Ratio
Selling, General and Administrative Expense (SG&A)
Capital Investment to Achieve Sustained Growth
Strategic Issue 3:Executing Effective Financial and Capital Policies
Financial and Capital Policies
Human Resource Policy
Environmental Resource Policy
@
Presentation File(PDF 1 MB)